Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to re-engineer the drug discovery and development process, providing more effective therapies to patients faster. The company will combine robust product development, cutting-edge biological and clinical data generation, and AI methods research, both translational and fundamental, applied to all steps of the drug discovery and development process.

The company aims to bring together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease.